COVID-19 Vaccine Implications For Corporate Executives
Access this research
Access all Real Estate Leaders content with a strategic subscription or buy this single report
Need help or have a question about this report? Contact us for assistance
Executive Summary
The emergence of COVID-19 vaccines with a 95% efficacy in clinical trials has provided businesses with new optimism that the end is in sight for the pandemic. This report provides corporate executives in operations, facilities and safety roles with an analysis of these announcements and a framework for business planning in 2021. To better understand what the vaccine developments mean for businesses, Verdantix analysed six promising vaccines and government rollout plans. An optimistic scenario will see the majority of the population inoculated by Q3 2021, but there are notable risks from manufacturing delays, distribution challenges and anti-vax campaigns. Verdantix recommends corporate leaders formulate plans across two time horizons; starting with the next 12 months with COVID-19 still circulating, followed by life beyond the pandemic, with the transition to the next normal.COVID-19 Vaccine: How To Reset Your Business Planning For 2021 And Beyond
Vaccine Breakthroughs Create Hope Major Economies Will Contain The Pandemic In Q3 2021
Speed Of Inoculation By Region Will Depend On The Effectiveness Of Delivery Supply Chains
COVID-19 Will Require Ongoing Monitoring And Potential Further Interventions
Corporate Executives Need To Reset Their Business Plans To Look Beyond The Pandemic
Businesses Need To Manage COVID-19 Fatigue And Infection Flare-Ups During 2021
Businesses Need To Develop Plans For Success In The Next Normal
Figure 2. Vaccine Distribution Plans For Australia, Canada, France, Germany, UK and US
Figure 3. Target Vaccine Rollout Timeline
Figure 4-1. COVID-19 Adaptations: Predictions For The Future (1/2)
Figure 4-2. COVID-19 Adaptations: Predictions For The Future (2/2)
About the Authors
Hugo Fuller
Senior Analyst
Hugo is a Senior Analyst in the Verdantix Industrial Transformation practice. His current research agenda explores the technologies within the industrial asset management soft...
Susan Clarke
Research Director
Susan leads the Verdantix Smart Buildings practice. Her current research agenda focuses on software solutions for real estate management including integrated workplace managem...
Chris Sayers
Senior Manager
Chris is a Senior Manager at Verdantix. His current research agenda targets enterprise AI integration and adoption, AI market trends and agentic AI. Chris joined Verdantix in ...
View ProfileOther related content
Verdantix data shows that 62% of capital project firms own software for the purpose of managing financial risk, with a further 31% either outsourcing the software or relying upon s...
Upcoming / 24 March, 2026
Disagreements between investors and the leadership teams of the firms they invest in are nothing new. However, when they unfold in public and involve major players, they tend to at...
23 February, 2026
-_main-image.jpg?Status=Master&sfvrsn=ec07938d_1)
North American retail is entering a new phase – one where physical stores are no longer relics of a pre-digital era, but the backbone of modern retail performance. With 80% of tr...
19 February, 2026
As organizations plan for 2026, corporate real estate leaders are no longer debating whether change is required, but where it will deliver the greatest operational and strategic im...
22 January, 2026
What if your buildings stopped operating as disconnected systems and started behaving like a single intelligent organism? In 2026, that vision is rapidly becoming reality. The 10...
16 January, 2026
In 2025, average UK office occupancy was around 40%, the highest level since the pandemic but still well below pre-pandemic norms. As organisations continue to bring people back in...
Upcoming / 26 February, 2026